| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALB | Common Stock | Options Exercise | $0 | +434 | +0.41% | $0.000000 | 105,356 | 31 Dec 2024 | Direct | F1 |
| transaction | ALB | Common Stock | Tax liability | $16,527 | -192 | -0.18% | $86.08 | 105,164 | 31 Dec 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALB | Restricted Stock Units | Options Exercise | $0 | -434 | -100% | $0.000000 | 0 | 31 Dec 2024 | Common Stock | 434 | Direct | F3, F4, F5 |
| Id | Content |
|---|---|
| F1 | The Reporting Person's holdings reported in Table 1, Column 5 include: 10,020 Restricted Stock Units ("RSUs") granted on February 24, 2023, and 21,155 RSUs granted on February 22, 2024, which were previously reported in Table 2 in Forms 4 filed 2/28/2023 and 2/26/2024, respectively. These RSUs will vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer (subject to the terms of the applicable award agreement). Starting with this report, RSUs subject to time-based vesting conditions will be reported in Table 1 at grant and in Column 5 as beneficially owned for consistency in reporting methodology amongst reporting persons of the Issuer. |
| F2 | Shares withheld to meet tax liabilities associated with vesting of RSUs. |
| F3 | Each RSU converts to 1 share of Common Stock. |
| F4 | RSUs granted on 02/25/2022. 95% vested on 12/31/2023 and remaining 5% vested on 12/31/2024. |
| F5 | No expiration date. |